Nanalysis Scientific (CVE:NSCI) Sets New 12-Month Low at $0.35

Nanalysis Scientific Corp. (CVE:NSCIGet Free Report)’s share price reached a new 52-week low during trading on Monday . The company traded as low as C$0.35 and last traded at C$0.38, with a volume of 432365 shares traded. The stock had previously closed at C$0.42.

Nanalysis Scientific Trading Up 3.9 %

The stock has a market cap of C$40.06 million, a price-to-earnings ratio of -2.32 and a beta of 0.82. The business’s fifty day simple moving average is C$0.47 and its 200 day simple moving average is C$0.45. The company has a debt-to-equity ratio of 71.36, a current ratio of 1.52 and a quick ratio of 1.11.

Insider Activity

In other news, Director Michal Okoniewski purchased 80,000 shares of Nanalysis Scientific stock in a transaction dated Monday, March 18th. The stock was bought at an average price of C$0.38 per share, with a total value of C$30,400.00. Corporate insiders own 6.99% of the company’s stock.

Nanalysis Scientific Company Profile

(Get Free Report)

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Featured Articles

Receive News & Ratings for Nanalysis Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanalysis Scientific and related companies with MarketBeat.com's FREE daily email newsletter.